title: Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.
authors.affiliation: VU University Medical Center, Department of Neurology, PO Box 7057, 1007 MB Amsterdam, the Netherlands. a.vennegoor@vumc.nl
authors.forename: A
authors.initials: A
authors.lastname: Vennegoor
authors.forename: M P
authors.initials: MP
authors.lastname: Wattjes
authors.forename: E T L
authors.initials: ET
authors.lastname: van Munster
authors.forename: R L
authors.initials: RL
authors.lastname: Kriekaart
authors.forename: B W
authors.initials: BW
authors.lastname: van Oosten
authors.forename: F
authors.initials: F
authors.lastname: Barkhof
authors.forename: J
authors.initials: J
authors.lastname: Killestein
authors.forename: C H
authors.initials: CH
authors.lastname: Polman
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000473:pathology*; D008279:Magnetic Resonance Imaging / Q000379:methods / Q000592:standards; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology*; D000069442:Natalizumab; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab